Ehab Elkhouly

Ehab Elkhouly, MD, MBA, serves as the Medical Director and Global/US Asset Lead for Biomarkers & Diagnostic at Amgen, where responsibilities include overseeing oncology biomarkers and companion diagnostics as a Global Medical Lead. Prior experience includes a role as Vice President of Clinical Affairs & Operations at Cancer Genetics, Inc., as well as positions as Senior Director and Director of Clinical Affairs & Operations within the same organization. Ehab earned an MBA from the University of California, Irvine - The Paul Merage School of Business between 2010 and 2012, and furthered education in Clinical Affairs through a program at the University of California, Irvine Division of Continuing Education from 2015 to 2016.